CHRISTOPHER BAILEY: Open Payments
NPI 1275602070 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,599 in 51 payments from 16 companies in 2025. Trend: 2023 $579 · 2024 $525 · 2025 $4,599
Speaker / faculty: $3,638Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 10 | $3,788 |
| ABBVIE INC. | 19 | $372 |
| Gilead Sciences, Inc. | 5 | $107 |
| Novo Nordisk Inc | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Braeburn Inc. | 2 | $37 |
| Seqirus USA Inc | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: SUBLOCADE, MAVYRET, UBRELVY, COBENFY, Rybelsus, BRIXADI, VRAYLAR, Epclusa.
Industry payments across KY — which companies pay providers there.
